154 related articles for article (PubMed ID: 18290771)
1. Steatosis in chronic hepatitis C: friend or foe?
Negro F
Liver Int; 2008 Mar; 28(3):294-6. PubMed ID: 18290771
[No Abstract] [Full Text] [Related]
2. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients.
Adinolfi LE; Utili R; Ruggiero G
Hepatology; 1999 Dec; 30(6):1530-1. PubMed ID: 10610353
[No Abstract] [Full Text] [Related]
3. [What does chronic hepatitis C steatosis mean?].
Asselah T; Ripault MP; Marcellin P
Gastroenterol Clin Biol; 2003 Dec; 27(12):1073-5. PubMed ID: 14770105
[No Abstract] [Full Text] [Related]
4. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and liver steatosis: when fat is not beautiful.
Negro F
J Hepatol; 2004 Mar; 40(3):533-5. PubMed ID: 15123371
[No Abstract] [Full Text] [Related]
7. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-beta-lipoproteinemia.
Colloredo G; Sonzogni A; Rubbia-Brandt L; Negro F
J Hepatol; 2004 Mar; 40(3):562-3. PubMed ID: 15123378
[No Abstract] [Full Text] [Related]
9. [Pathomechanism of metabolic disorders in HCV infection].
Boroń-Kaczmarska A
Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
[TBL] [Abstract][Full Text] [Related]
10. Retinol-binding protein 4 as a circulating marker of hepatic steatosis.
Fujita T
Hepatology; 2008 Nov; 48(5):1725; author reply 1725-6. PubMed ID: 18972436
[No Abstract] [Full Text] [Related]
11. [Non-alcoholic fatty liver disease].
Calderaro J; Zafrani ES
Ann Pathol; 2010 Dec; 30(6):413-20. PubMed ID: 21167426
[No Abstract] [Full Text] [Related]
12. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
[TBL] [Abstract][Full Text] [Related]
13. [Pathology of chronic hepatitis C and its histological features].
Shiga J; Fukusato T; Fukushima J
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):408-11. PubMed ID: 15359832
[No Abstract] [Full Text] [Related]
14. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
15. A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.
Patel K; Muir A; McHutchison JG; Patton HM
Am J Gastroenterol; 2003 May; 98(5):952-5. PubMed ID: 12809813
[No Abstract] [Full Text] [Related]
16. Gender, fatty liver and GGT.
Carulli L; Lonardo A; Lombardini S; Marchesini G; Loria P
Hepatology; 2006 Jul; 44(1):278-9. PubMed ID: 16799969
[No Abstract] [Full Text] [Related]
17. Steatosis in chronic hepatitis C.
Guidi M; Muratori P; Granito A; Muratori L; Lenzi M; Bianchi FB
Gut; 2006 Jul; 55(7):1047; author reply 1047-8. PubMed ID: 16766755
[No Abstract] [Full Text] [Related]
18. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
19. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
20. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
